Medycyna Pharmaceutical Private Limited

Medycyna Pharmaceutical Private Limited Corporate Identification Number is (CIN) U51397BR2020PTC049537 and its registration number is 049537. Primary email address to contact is me*****@gmail.com and the registered address is ALOK KUMAR S*****BR 801503 IN

Directors of Medycyna Pharmaceutical Private Limited are KANTLAL GUPTA , UMAKANT SHARMA and SACHCHIDANAND SINGH .

Medycyna Pharmaceutical Private Limited is a Private incorporated on 07 Dec 2020. It is classified as a CIN- and is registered at Registrar of Companies, Bihar. Its authorized share capital is 500000 and its paid-up capital is 300000.

Medycyna Pharmaceutical Private Limited Annual General Meeting (AGM) was last held on None and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on None.

Current status of Medycyna Pharmaceutical Private Limited is - None.

BASIC INFORMATION

  • CINU51397BR2020PTC049537
  • Registration Number049537
  • Date of Incorporation 07 Dec 2020
  • Registered StateBihar
  • Registration Of Companies RoC - Patna
  • CategoryCompany limited by Shares
  • Sub CategoryNon-govt company
  • Company Class Private
  • Company StatusNone

SHARE CAPITAL INFORMATION

  • Authorized Capital500000
  • Paidup Capital300000

LISTING AND ANNUAL INFORMATION

  • Whether Listed or notUnlisted
  • Date of last AGMNone
  • Date of Balance Sheet None
  • Principal Business ActivityWholesale trade and commission trade, except of motor vehicles and motorcycles

CONTACT INFORMATION

  • Email Idme*****@gmail.com
  • Registered Office AddressALOK KUMAR S*****BR 801503 IN

Buy Company's Documents

Unlock complete report of this company by accessing all historical financials and other documents present on MCA in just INR 500


Top Legal Queries

Get answers from the best experts within minutes!

Came Up With A Unique Company Name? Check Company Name Availability Instantly With Legistify.

© Legistify Services Pvt. Ltd.

Home|About|Contact

-->
Ask Free Query
Get free answers from experts